EGFR and neoplasm: Our results begin to fill this gap by supporting the notion that EGFR- and mechanotransductive signaling act in tandem to promote proliferation in GBM cells, although further investigations are necessary to determine if this is a general phenomenon of mechanosensing or is specific to GBM and perhaps other tumor types.